MyBio News | New Exclusive Partnership with QIAGEN

As of the 1st of April 2024, MyBio Ltd. will be the main point of contact for sales and supply of QIAGEN’s world leading “Sample to Insight” solutions for life science customers throughout the island of Ireland. 

MyBio's Founder & CEO, Linda Nolan is delighted to announce this new exclusive partnership with QIAGEN to distribute their Life Science research product portfolio throughout Ireland and Northern Ireland.

This agreement establishes that MyBio Ltd will exclusively distribute QIAGEN Life Science products and technologies throughout the island of Ireland. This exclusivity refers to Life Science products for the respective customer base and does not extend to other product portfolios of QIAGEN such as IVD regulated products, HID, Instrument Service or QDI products or customer segments.

Under this new agreement MyBio will be responsible for marketing QIAGEN Life Science technologies for the molecular analysis of any type of biological sample; from sample collection, its disruption, the purification of DNA, RNA and proteins and its identification and quantification using the most advanced technologies on the market.

MyBio is proud of it's deep ties within the Academic Research, Biopharma and AgBio industries in Ireland since being established in 2009 and now look forward to serving existing and future customers with QIAGEN as a new supply partner.

For further information, keep up to date with MyBio social channels and our website www.mybio.ie/QIAGEN 

For new customers wanting to set-up an account with MyBio, please complete our MyBio New Customer Registration Form or contact our Customer Support Team at info@mybio.ie 

We look forward to this new chapter ahead with our continued and dedicated focus for excellence, to empower meaningful change.